Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2025-12-25 @ 12:01 PM
NCT ID: NCT03526861
Term: Cerebrovascular accident
Organ System: Nervous system disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 20.0
Notes: None
Study: NCT03526861
Study Brief: Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 97 View
EG001 1 1 98 View
EG002 0 0 94 View
EG003 0 0 11 View
EG004 0 0 13 View
EG005 0 0 12 View
EG006 0 0 14 View
EG007 0 0 6 View
EG008 0 0 234 View
EG009 0 0 234 View